APO Research
Talk to an analyst

APO RESEARCH · REPORT

No-Exam Life Insurance

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global No-Exam Life Insurance Market Outlook and Growth Opportunities 2026

4 June 2026192 pages

Choose your research edition.

Industry ResearchNo-Exam Life Insurance Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal No-Exam Life Insurance Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal No-Exam Life Insurance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal No-Exam Life Insurance Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal No-Exam Life Insurance Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global No-Exam Life Insurance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for No-Exam Life Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for No-Exam Life Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for No-Exam Life Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the No-Exam Life Insurance market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the No-Exam Life Insurance market include State Farm, AAA, Pacific Life, Protective, Symetra, Corebridge, Legal & General America, Transamerica and Fidelity Life, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global No-Exam Life Insurance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of No-Exam Life Insurance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents No-Exam Life Insurance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global No-Exam Life Insurance market.

No-Exam Life Insurance Segment by Company

State Farm

AAA

Pacific Life

Protective

Symetra

Corebridge

Legal & General America

Transamerica

Fidelity Life

Lincoln Financial

John Hancock

Mutual of Omaha

New York Life

Nationwide Mutual Insurance Company

No-Exam Life Insurance Segment by Type

Term Life Insurance

Permanent Life Insurance

Annuity Insurance

Savings Insurance

No-Exam Life Insurance Segment by Application

Children

Adults

Senior Citizens

No-Exam Life Insurance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global No-Exam Life Insurance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the No-Exam Life Insurance key companies, revenue, market share, and recent developments.

3. To split the No-Exam Life Insurance breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions No-Exam Life Insurance market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify No-Exam Life Insurance significant trends, drivers, influence factors in global and regions.

6. To analyze No-Exam Life Insurance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global No-Exam Life Insurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of No-Exam Life Insurance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of No-Exam Life Insurance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global No-Exam Life Insurance industry.

Chapter 3: Detailed analysis of No-Exam Life Insurance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of No-Exam Life Insurance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of No-Exam Life Insurance in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. No-Exam Life Insurance Industry Trends Table 2. No-Exam Life Insurance Industry Drivers Table 3. No-Exam Life Insurance Industry Opportunities and Challenges Table 4. No-Exam Life Insurance Industry Restraints Table 5. Global No-Exam Life Insurance Revenue by Company (US$ Million) & (2021-2026) Table 6. Global No-Exam Life Insurance Revenue Share by Company (2021-2026) Table 7. Global No-Exam Life Insurance Company Ranking, (2024-2026) & (US$ Million) Table 8. Global No-Exam Life Insurance Key Company Manufacturing Base & Headquarters Table 9. Global No-Exam Life Insurance Company, Product Type & Application Table 10. Global No-Exam Life Insurance Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global No-Exam Life Insurance by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Term Life Insurance Table 15. Significant Companies of Permanent Life Insurance Table 16. Significant Companies of Annuity Insurance Table 17. Significant Companies of Savings Insurance Table 18. Global No-Exam Life Insurance Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global No-Exam Life Insurance Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global No-Exam Life Insurance Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global No-Exam Life Insurance Sales Value Share by Type (2021-2026) Table 22. Global No-Exam Life Insurance Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Children Table 24. Significant Companies of Adults Table 25. Significant Companies of Senior Citizens Table 26. Global No-Exam Life Insurance Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global No-Exam Life Insurance Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global No-Exam Life Insurance Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global No-Exam Life Insurance Sales Value Share by Application (2021-2026) Table 30. Global No-Exam Life Insurance Sales Value Share by Application (2027-2032) Table 31. Global No-Exam Life Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global No-Exam Life Insurance Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global No-Exam Life Insurance Sales Value Share by Region (2021-2026) Table 34. Global No-Exam Life Insurance Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global No-Exam Life Insurance Sales Value Share by Region (2027-2032) Table 36. Global No-Exam Life Insurance Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global No-Exam Life Insurance Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global No-Exam Life Insurance Sales Value Market Share by Country (2021-2026) Table 39. Global No-Exam Life Insurance Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global No-Exam Life Insurance Sales Value Market Share by Country (2027-2032) Table 41. State Farm Company Information Table 42. State Farm Business Overview Table 43. State Farm No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. State Farm No-Exam Life Insurance Product Portfolio Table 45. State Farm Recent Development Table 46. AAA Company Information Table 47. AAA Business Overview Table 48. AAA No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. AAA No-Exam Life Insurance Product Portfolio Table 50. AAA Recent Development Table 51. Pacific Life Company Information Table 52. Pacific Life Business Overview Table 53. Pacific Life No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Pacific Life No-Exam Life Insurance Product Portfolio Table 55. Pacific Life Recent Development Table 56. Protective Company Information Table 57. Protective Business Overview Table 58. Protective No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Protective No-Exam Life Insurance Product Portfolio Table 60. Protective Recent Development Table 61. Symetra Company Information Table 62. Symetra Business Overview Table 63. Symetra No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Symetra No-Exam Life Insurance Product Portfolio Table 65. Symetra Recent Development Table 66. Corebridge Company Information Table 67. Corebridge Business Overview Table 68. Corebridge No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Corebridge No-Exam Life Insurance Product Portfolio Table 70. Corebridge Recent Development Table 71. Legal & General America Company Information Table 72. Legal & General America Business Overview Table 73. Legal & General America No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Legal & General America No-Exam Life Insurance Product Portfolio Table 75. Legal & General America Recent Development Table 76. Transamerica Company Information Table 77. Transamerica Business Overview Table 78. Transamerica No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Transamerica No-Exam Life Insurance Product Portfolio Table 80. Transamerica Recent Development Table 81. Fidelity Life Company Information Table 82. Fidelity Life Business Overview Table 83. Fidelity Life No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Fidelity Life No-Exam Life Insurance Product Portfolio Table 85. Fidelity Life Recent Development Table 86. Lincoln Financial Company Information Table 87. Lincoln Financial Business Overview Table 88. Lincoln Financial No-Exam Life Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Lincoln Financial No-Exam Life Insurance Product Portfolio Table 90. Lincoln Financial Recent Development Table 91. John Hancock Company Information Table 92. John Hancock Business Overview Table 93. John Hancock No-Exam Life Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. John Hancock No-Exam Life Insurance Product Portfolio Table 95. John Hancock Recent Development Table 96. Mutual of Omaha Company Information Table 97. Mutual of Omaha Business Overview Table 98. Mutual of Omaha No-Exam Life Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Mutual of Omaha No-Exam Life Insurance Product Portfolio Table 100. Mutual of Omaha Recent Development Table 101. New York Life Company Information Table 102. New York Life Business Overview Table 103. New York Life No-Exam Life Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. New York Life No-Exam Life Insurance Product Portfolio Table 105. New York Life Recent Development Table 106. Nationwide Mutual Insurance Company Company Information Table 107. Nationwide Mutual Insurance Company Business Overview Table 108. Nationwide Mutual Insurance Company No-Exam Life Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Nationwide Mutual Insurance Company No-Exam Life Insurance Product Portfolio Table 110. Nationwide Mutual Insurance Company Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. No-Exam Life Insurance Product Image Figure 2. Global No-Exam Life Insurance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global No-Exam Life Insurance Market Size (2021-2032) & (US$ Million) Figure 4. Global No-Exam Life Insurance Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Term Life Insurance Image Figure 8. Permanent Life Insurance Image Figure 9. Annuity Insurance Image Figure 10. Savings Insurance Image Figure 11. Global No-Exam Life Insurance Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global No-Exam Life Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global No-Exam Life Insurance Sales Value Share by Type (2021-2032) Figure 14. Children Image Figure 15. Adults Image Figure 16. Senior Citizens Image Figure 17. Global No-Exam Life Insurance Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global No-Exam Life Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global No-Exam Life Insurance Sales Value Share by Application (2021-2032) Figure 20. Global No-Exam Life Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global No-Exam Life Insurance Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America No-Exam Life Insurance Sales Value (2021-2032) & (US$ Million) Figure 23. North America No-Exam Life Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe No-Exam Life Insurance Sales Value (2021-2032) & (US$ Million) Figure 25. Europe No-Exam Life Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific No-Exam Life Insurance Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific No-Exam Life Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America No-Exam Life Insurance Sales Value (2021-2032) & (US$ Million) Figure 29. South America No-Exam Life Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa No-Exam Life Insurance Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa No-Exam Life Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt No-Exam Life Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Term Life Insurance
  • Permanent Life Insurance
  • Annuity Insurance
  • Savings Insurance
Applications
  • Children
  • Adults
  • Senior Citizens
Companies covered
  • State Farm
  • AAA
  • Pacific Life
  • Protective
  • Symetra
  • Corebridge
  • Legal & General America
  • Transamerica
  • Fidelity Life
  • Lincoln Financial
  • John Hancock
  • Mutual of Omaha
  • New York Life
  • Nationwide Mutual Insurance Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global No-Exam Life Insurance Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global No-Exam Life Insurance Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 No-Exam Life Insurance Market Dynamics
  1. 2.1 No-Exam Life Insurance Industry Trends
  2. 2.2 No-Exam Life Insurance Industry Drivers
  3. 2.3 No-Exam Life Insurance Industry Opportunities and Challenges
  4. 2.4 No-Exam Life Insurance Industry Restraints
3 No-Exam Life Insurance Market by Company
  1. 3.1 Global No-Exam Life Insurance Company Revenue Ranking in 2025
  2. 3.2 Global No-Exam Life Insurance Revenue by Company (2021-2026)
  3. 3.3 Global No-Exam Life Insurance Company Ranking (2024-2026)
  4. 3.4 Global No-Exam Life Insurance Company Manufacturing Base and Headquarters
  5. 3.5 Global No-Exam Life Insurance Company Product Type and Application
  6. 3.6 Global No-Exam Life Insurance Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global No-Exam Life Insurance Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 No-Exam Life Insurance Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 No-Exam Life Insurance Market by Type
  1. 4.1 No-Exam Life Insurance Type Introduction
  2. 4.1.1 Term Life Insurance
  3. 4.1.2 Permanent Life Insurance
  4. 4.1.3 Annuity Insurance
  5. 4.1.4 Savings Insurance
  6. 4.2 Global No-Exam Life Insurance Sales Value by Type
  7. 4.2.1 Global No-Exam Life Insurance Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global No-Exam Life Insurance Sales Value by Type (2021-2032)
  9. 4.2.3 Global No-Exam Life Insurance Sales Value Share by Type (2021-2032)
5 No-Exam Life Insurance Market by Application
  1. 5.1 No-Exam Life Insurance Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.1.3 Senior Citizens
  5. 5.2 Global No-Exam Life Insurance Sales Value by Application
  6. 5.2.1 Global No-Exam Life Insurance Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global No-Exam Life Insurance Sales Value by Application (2021-2032)
  8. 5.2.3 Global No-Exam Life Insurance Sales Value Share by Application (2021-2032)
6 No-Exam Life Insurance Regional Value Analysis
  1. 6.1 Global No-Exam Life Insurance Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global No-Exam Life Insurance Sales Value by Region (2021-2032)
  3. 6.2.1 Global No-Exam Life Insurance Sales Value by Region: 2021-2026
  4. 6.2.2 Global No-Exam Life Insurance Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America No-Exam Life Insurance Sales Value (2021-2032)
  7. 6.3.2 North America No-Exam Life Insurance Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe No-Exam Life Insurance Sales Value (2021-2032)
  10. 6.4.2 Europe No-Exam Life Insurance Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific No-Exam Life Insurance Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific No-Exam Life Insurance Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America No-Exam Life Insurance Sales Value (2021-2032)
  16. 6.6.2 South America No-Exam Life Insurance Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa No-Exam Life Insurance Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa No-Exam Life Insurance Sales Value Share by Country, 2025 VS 2032
7 No-Exam Life Insurance Country-level Value Analysis
  1. 7.1 Global No-Exam Life Insurance Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global No-Exam Life Insurance Sales Value by Country (2021-2032)
  3. 7.2.1 Global No-Exam Life Insurance Sales Value by Country (2021-2026)
  4. 7.2.2 Global No-Exam Life Insurance Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt No-Exam Life Insurance Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt No-Exam Life Insurance Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt No-Exam Life Insurance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 State Farm
  2. 8.1.1 State Farm Company Information
  3. 8.1.2 State Farm Business Overview
  4. 8.1.3 State Farm No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  5. 8.1.4 State Farm No-Exam Life Insurance Product Portfolio
  6. 8.1.5 State Farm Recent Developments
  7. 8.2 AAA
  8. 8.2.1 AAA Company Information
  9. 8.2.2 AAA Business Overview
  10. 8.2.3 AAA No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AAA No-Exam Life Insurance Product Portfolio
  12. 8.2.5 AAA Recent Developments
  13. 8.3 Pacific Life
  14. 8.3.1 Pacific Life Company Information
  15. 8.3.2 Pacific Life Business Overview
  16. 8.3.3 Pacific Life No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pacific Life No-Exam Life Insurance Product Portfolio
  18. 8.3.5 Pacific Life Recent Developments
  19. 8.4 Protective
  20. 8.4.1 Protective Company Information
  21. 8.4.2 Protective Business Overview
  22. 8.4.3 Protective No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Protective No-Exam Life Insurance Product Portfolio
  24. 8.4.5 Protective Recent Developments
  25. 8.5 Symetra
  26. 8.5.1 Symetra Company Information
  27. 8.5.2 Symetra Business Overview
  28. 8.5.3 Symetra No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Symetra No-Exam Life Insurance Product Portfolio
  30. 8.5.5 Symetra Recent Developments
  31. 8.6 Corebridge
  32. 8.6.1 Corebridge Company Information
  33. 8.6.2 Corebridge Business Overview
  34. 8.6.3 Corebridge No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Corebridge No-Exam Life Insurance Product Portfolio
  36. 8.6.5 Corebridge Recent Developments
  37. 8.7 Legal & General America
  38. 8.7.1 Legal & General America Company Information
  39. 8.7.2 Legal & General America Business Overview
  40. 8.7.3 Legal & General America No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Legal & General America No-Exam Life Insurance Product Portfolio
  42. 8.7.5 Legal & General America Recent Developments
  43. 8.8 Transamerica
  44. 8.8.1 Transamerica Company Information
  45. 8.8.2 Transamerica Business Overview
  46. 8.8.3 Transamerica No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Transamerica No-Exam Life Insurance Product Portfolio
  48. 8.8.5 Transamerica Recent Developments
  49. 8.9 Fidelity Life
  50. 8.9.1 Fidelity Life Company Information
  51. 8.9.2 Fidelity Life Business Overview
  52. 8.9.3 Fidelity Life No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fidelity Life No-Exam Life Insurance Product Portfolio
  54. 8.9.5 Fidelity Life Recent Developments
  55. 8.10 Lincoln Financial
  56. 8.10.1 Lincoln Financial Company Information
  57. 8.10.2 Lincoln Financial Business Overview
  58. 8.10.3 Lincoln Financial No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lincoln Financial No-Exam Life Insurance Product Portfolio
  60. 8.10.5 Lincoln Financial Recent Developments
  61. 8.11 John Hancock
  62. 8.11.1 John Hancock Company Information
  63. 8.11.2 John Hancock Business Overview
  64. 8.11.3 John Hancock No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  65. 8.11.4 John Hancock No-Exam Life Insurance Product Portfolio
  66. 8.11.5 John Hancock Recent Developments
  67. 8.12 Mutual of Omaha
  68. 8.12.1 Mutual of Omaha Company Information
  69. 8.12.2 Mutual of Omaha Business Overview
  70. 8.12.3 Mutual of Omaha No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mutual of Omaha No-Exam Life Insurance Product Portfolio
  72. 8.12.5 Mutual of Omaha Recent Developments
  73. 8.13 New York Life
  74. 8.13.1 New York Life Company Information
  75. 8.13.2 New York Life Business Overview
  76. 8.13.3 New York Life No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  77. 8.13.4 New York Life No-Exam Life Insurance Product Portfolio
  78. 8.13.5 New York Life Recent Developments
  79. 8.14 Nationwide Mutual Insurance Company
  80. 8.14.1 Nationwide Mutual Insurance Company Company Information
  81. 8.14.2 Nationwide Mutual Insurance Company Business Overview
  82. 8.14.3 Nationwide Mutual Insurance Company No-Exam Life Insurance Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Nationwide Mutual Insurance Company No-Exam Life Insurance Product Portfolio
  84. 8.14.5 Nationwide Mutual Insurance Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst